The state of the hepatobiliary system in adolescents with type 1 diabetes mellitus
DOI:
https://doi.org/10.15574/SP.2023.135.44Keywords:
adolescents, diabetes mellitus type 1, glycemic control, alanine aminotransferase, non-alcoholic fatty liver disease, glycogenic hepatopathyAbstract
Diabetes mellitus type 1 (DMT1) is one of the diseases in which liver lesions such as glycogenic hepatopathy and hepatic steatosis are frequently observed which makes our study appropriate.
Purpose - to study the state of the hepatobiliary system in adolescents with DMT1 based on the results of a biochemical blood test, ultrasound examination of the hepatobiliary system and dynamic monitoring.
Materials and methods. The study included 173 adolescents (87 girls and 86 boys aged 10 to 18 years who have DMT1 and were in the endocrinology department of the SI «Institute for Children and Adolescents Health Care of the NAMS of Ukraine»). Patients were divided according to the level of glycaemic control targets (GCT): the Group 1 - optimal (glycosylated hemoglobin (HbA1c) <7.0%), the Group 2 - suboptimal (HbA1c = 7.0-9.0%), the Group 3 - high-risk GCT (HbA1c >9.0%). The Control group included 20 healthy adolescents. All patients underwent a biochemical blood test and ultrasound.
Results. Most of the examined adolescents had pain, dyspeptic syndromes and an increased size of the liver on ultrasonography regardless of the level of GCT. Ultrasound signs of hepatic steatosis were most often determined in patients with the Group 3. Dynamic observation indicated the absence of positive dynamics in reducing the size of the liver and normalizing the echogenicity of its parenchyma in 50% of patients, even when optimal GCT is reached. The majority of adolescents with DMT1 had hypotension of the gallbladder, and thickening of the gallbladder walls and the presence of biliary sludge were more often observed in patients with Groups 2 and 3.
In the Groups 2 and 3 increased activity of alanine aminotransferase was revealed, which against the background of compensation for DMT1, decreased in only half of the patients. Lipidogram parameters were atherogenic in all patients, regardless of the level of GCT.
Conclusions. The study revealed a high incidence of hepatopathy in adolescents with DMT1, which requires careful follow-up. The diagnostic algorithm requires the inclusion of non-invasive tests of the hepatobiliary system.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the authors.
References
Al-Hussaini AA, Sulaiman NM, Alzahrani MD, Alenizi AS, Khan M. (2012). Prevalence of hepatopathy in type 1 diabetic children. BMC Pediatr. 12: 160. https://doi.org/10.1186/1471-2431-12-160; PMid:23039762 PMCid:PMC3506494
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M et al. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 67(1): 328-357. https://doi.org/10.1002/hep.29367; PMid:28714183
Cusi K, Sanyal AJ, Zhang S, Hartman ML, BueValleskey JM, Hoogwerf BJ et al. (2017). Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes. Diabetes Obes Metab. 19(11): 1630-1634. https://doi.org/10.1111/dom.12973; PMid:28417532
DiMeglio LA, Acerini CL, Codner E, Craig ME, Hofer SE, Pillay K et al. (2018). ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes. 19 Suppl 27: 105-114. https://doi.org/10.1111/pedi.12737; PMid:30058221
Elzubeir A, Alam S, Sington J. (2021). Image of the month: Mauriac variant: a rare complication of poorly controlled diabetes. Clin Med (Lond). 21(1): 76-77. https://doi.org/10.7861/clinmed.2020-0826; PMid:33479072 PMCid:PMC7850216
Gaiani S, Avogaro A, Bombonato GC, Bolognesi M, Amor F, Vigili de Kreutzenberg S et al. (2009). Nonalcoholic fatty liver disease (NAFLD) in nonobese patients with diabetes: Prevalence and relationships with hemodynamic alterations detected with Doppler sonography. J Ultrasound. 12(1): 1-5. https://doi.org/10.1016/j.jus.2008.12.002; PMid:23396636 PMCid:PMC3553245
International Diabetes Federation. (2021). IDF Diabetes Atlas, 10th edn. Brussels, Belgium. URL: https://www.diabetesatlas.org.
Irani NR, Venugopal K, Kontorinis N, Lee M, Sinniah R, Bates TR. (2015). Glycogenic hepatopathy is an under-recognised cause of hepatomegaly and elevated liver transaminases in type 1 diabetes mellitus. Intern Med J. 45(7): 777-779. https://doi.org/10.1111/imj.12807; PMid:26134697
Jiang S, Tang X, Wang K, Liang Y, Qian Y, Lu C et al. (2019). Hepatic functional and pathological changes of type 1 diabetic mice in growing and maturation time. J Cell Mol Med. 23(8): 5794-5807. https://doi.org/10.1111/jcmm.14504; PMid:31222979 PMCid:PMC6652934
Julián MT, Alonso N, Ojanguren I, Pizarro E, Ballestar E, Puig-Domingo M. (2015). Hepatic glycogenosis: An underdiagnosed complication of diabetes mellitus?. World J Diabetes. 6(2): 321-325. https://doi.org/10.4239/wjd.v6.i2.321; PMid:25789113 PMCid:PMC4360425
Khoury J, Zohar Y, Shehadeh N, Saadi T. (2018). Glycogenic hepatopathy. Hepatobiliary Pancreat Dis Int. 17(2): 113-118. https://doi.org/10.1016/j.hbpd.2018.02.006; PMid:29709217
MOZ Ukrainy (2023). Standart medychnoi dopomohy «Tsukrovyi diabet u ditei». Nakaz Ministerstva okhorony zdorovia Ukrainy vid 28.02.2023 No. 413.
MOZ Ukrainy. (2006). Protokol nadannia medychnoi dopomohy ditiam za spetsialnistiu «Dytiacha endokrynolohiia». Nakaz Ministerstva okhorony zdorovia Ukrainy vid 27.04.2006 No. 254 iz zminamy, vnesenymy zghidno z Nakazamy Ministerstva okhorony zdorovia vid 03.02.2009 No. 55, vid 07.10.2013 No. 864.
Murata F, Horie I, Ando T, Isomoto E, Hayashi H, Akazawa S et al. (2012). A case of glycogenic hepatopathy developed in a patient with new-onset fulminant type 1 diabetes: the role of image modalities in diagnosing hepatic glycogen deposition including gradient-dual-echo MRI. Endocr J. 59(8): 669-676. https://doi.org/10.1507/endocrj.EJ12-0081; PMid:22673296
Regnell SE, Lernmark Å. (2011). Hepatic steatosis in type 1 diabetes. Rev Diabet Stud. 8(4): 454-467. https://doi.org/10.1900/RDS.2011.8.454; PMid:22580727 PMCid:PMC3359690
Stadler M, Bollow E, Fritsch M, Kerner W, Schuetz-Fuhrmann I, Krakow D et al. (2017). Prevalence of elevated liver enzymes in adults with type 1 diabetes: A multicentre analysis of the German/Austrian DPV database. Diabetes Obes Metab. 19(8): 1171-1178. https://doi.org/10.1111/dom.12929; PMid:28256088
Tilg H, Moschen AR, Roden M. (2017). NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 14(1): 32-42. https://doi.org/10.1038/nrgastro.2016.147; PMid:27729660
Torbenson M, Chen YY, Brunt E, Cummings OW, Gottfried M, Jakate S et al. (2006). Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus. Am J Surg Pathol. 30(4): 508-513. https://doi.org/10.1097/00000478-200604000-00012; PMid:16625098
Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R et al. (2017). NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 64(2): 319-334. https://doi.org/10.1097/MPG.0000000000001482; PMid:28107283 PMCid:PMC5413933
West J, Brousil J, Gazis A, Jackson L, Mansell P, Bennett A et al. (2006). Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus. QJM. 99(12): 871-876. https://doi.org/10.1093/qjmed/hcl116; PMid:17121768
Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E et al. (2019). Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology. 69(6): 2672-2682. https://doi.org/10.1002/hep.30251; PMid:30179269
Zelinska NB, Rudenko NG, Globa EV, Rudenko OV, Grishchenko КV, Kavetska YS. (2021). Diseases of the endocrine system in children in Ukraine and the provision of specialized care to pediatric patients in 2020. Ukrainian Journal of Pediatric Endocrinology. 2: 4-14. https://doi.org/10.30978/UJPE2021-2-4
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
